Abstract
Purpose
To analyze the causes, success rate, and the changes of Jones tube length in endoscopic conjunctivodacryocystorhinostomy (CDCR) reoperation cases.
Methods
The medical records of 40 patients (41 eyes, a total of 52 cases) who underwent reoperation of CDCR with Jones tube reinsertion using an endoscope from January 2013 to December 2018 were retrospectively reviewed. We analyzed the success rate, causes of reoperation, changes in lengths of used tubes, and the average interval times between operations.
Results
The most common cause of reoperation was medial tube migration (53.8%). As in other causes, tube loss (17.3%), obstructions related with conjunctival overgrowth or granulation (13.46%), lateral tube migration (11.53%), iatrogenic removal (1.92%), and acute dacryocystitis (1.92%) followed. In patients with medial tube migration, the average tube length used in reoperations decreased by approximately 1.11 mm compared to prior operations. In cases of lateral tube migration, the average tube length increased approximately 1.00 mm after the reoperation. The success rate of reoperations was 78.04%. The average interval time between the initial operation and the first reoperation was 52 months. In cases with several reoperations, the interval time decreased as the number of reoperations increased.
Conclusions
Because medial tube migration was found to be the most common cause of reoperations, it should be considered as a potential problem when performing surgery. The changes in the lengths of inserted Jones tubes were related to certain types of complication, which affected the prognoses. In endoscopic CDCR reoperations, the success rate was favorable. In recurrent cases, the average interval time between reoperations decreased as the number of operations increased.
References
3. Liarakos VS, Boboridis KG, Mavrikakis E, Mavrikakis I. Management of canalicular obstructions. Curr Opin Ophthalmol. 2009; 20:395–400.
4. Lim C, Martin P, Benger R, et al. Lacrimal canalicular bypass abdominal with the Lester Jones tube. Am J Ophthalmol. 2004; 137:101–8.
5. Rose GE, Welham RA. Jones' lacrimal canalicular bypass tubes: twenty-five years' experience. Eye (Lond). 1991; 5:13–1.
6. Steele EA. Conjunctivodacryocystorhinostomy with Jones tube: a history and update. Curr Opin Ophthalmol. 2016; 27:439–42.
7. Rosen N, Ashkenazi I, Rosner M. Patient dissatisfaction after abdominalally successful abdominal with Jones tube. Am J Ophthalmol. 1994; 117:636–42.
8. Sekhar GC, Dortzbach RK, Gonnering RS, Lemke BN. Problems associated with abdominal. Am J Ophthalmol. 1991; 112:502–6.
9. Vicinanzo MG, Allamneni C, Compton CJ, et al. The prevalence of air regurgitation and its consequences after abdominal and dacryocystorhinostomy in continuous positive airway pressure patients. Ophthal Plast Reconstr Surg. 2015; 31:269–71.
10. Ginat DT, Freitag SK. Orbital emphysema complicating Jones tube placement in a patient treated with continuous positive airway pressure. Ophthal Plast Reconstr Surg. 2015; 31:e25.
11. Kreis AJ, Mehat MS, Madge SN. Periorbital emphysema: an abdominal complication of lacrimal canalicular bypass surgery with the Lester-Jones tube. Clin Experiment Ophthalmol. 2014; 42:201–2.
12. Athanasiov PA, Madge S, Kakizaki H, Selva D. A review of bypass tubes for proximal lacrimal drainage obstruction. Surv Ophthalmol. 2011; 56:252–66.
13. Na J, Lee S, Park J, et al. Surgical outcomes of endonasal abdominal according to Jones tube location. J Craniofac Surg. 2017; 28:e500–3.
14. Han YS, Baek SH. Clinical evaluation of endoscopic endonasal abdominal (CDCR) with Jones tube placement. J Korean Ophthalmol Soc. 2004; 45:1221–6.
15. Trotter WL, Meyer DR. Endoscopic conjunctivodacryocystorhinostomy with Jones tube placement. Ophthalmology. 2000; 107:1206–9.
16. Kim SW, Lee JK, Lee TS. Comparison of surgical results between endoscopic and conventional conjunctivodacryocystorhinostomy. J Korean Ophthalmol Soc. 2000; 41:314–9.
17. Park MS, Chi MJ, Baek SH. Clinical study of endoscopic abdominal abdominal with Jones tube placement. Ophthalmologica. 2007; 221:36–40.
18. Bartley GB, Gustafson RO. Complications of malpositioned Jones tube. Am J Ophthalmol. 1990; 109:66–9.
19. Chung HS, Han DK, Lee KY. Conjunctivodacryocystorhinostomy with Jones Tube. J Korean Ophthalmol Soc. 1985; 26:215–9.
20. Hwang JG, Kwak MS. Clinical experience of lacrimal surgery. J Korean Ophthalmol Soc. 1998; 39:17–24.
21. Nissen JN, Sørensen T. Conjunctivodacryocystorhinostomy. A study of 21 cases. Acta Ophthalmol (Copenh). 1987; 65:30–6.
22. Gladstone GJ, Putterman AM. A modified glass tube for conjunctivodacryocystorhinostomy. Arch Ophthalmol. 1985; 103:1229–30.
23. Witters E, Mombaerts I. The survival of an angled extended Jones' tube. Br J Ophthalmol. 2015; 99:1523–6.
25. Fan X, Bi X, Fu Y, et al. The use of Medpor coated tear drainage tube in abdominal. Eye (Lond). 2008; 22:1148–53.
26. Chang M, Lee H, Park M, Baek S. abdominal outcomes of abdominal endonasal abdominal with Jones tube placement: a thirteen-year experience. J Craniomaxillofac Surg. 2015; 43:7–10.
27. Choi WC, Yang SW. Endoscopy-guided transcaruncular Jones tube intubation without dacryocystorhinostomy. Jpn J Ophthalmol. 2006; 50:141–6.
28. Lee TS, Lee H. Purse-string suture technique for Jones tube abdominal in abdominal. J Korean Ophthalmol Soc. 2008; 49:1553–8.
29. Vigo RL, Ortiz-Basso T, Vilas MN, Prémoli J. A millimetric ruler for Lester Jones tube placement in conjunctivodacryocystorhinostomy. Clinical Ophthalmology. 2015; 9:1523–30.
30. Hollsten DA. Complications of lacrimal surgery. Int Ophthalmol Clin. 1992; 32:49–66.
31. Welham RA, Guthoff R. The Lester Jones tube: a 15-year fol-low-up Graefes. Arch Clin Exp Ophthalmol. 1985; 223:106–8.
32. Zilelioglu G, Gunduz K. Conjunctivodacryocystorhinostomy with Jones tube. A 10-year study. Doc Ophthalmol. 1996; 92:97–105.
33. Can I, Aribal E, Yarangumeli A, et al. Changes in the conjunctival flora after abdominal (CDCR): a abdominal report. Eur J Ophthalmol. 1998; 8:142–7.
34. Seo IH, Lee TS. Five-year study of 120 endoscopic abdominal using porous polyethylene-coated tear drain. J Korean Ophthalmol Soc. 2009; 50:1289–94.
Table 1.
Characteristic | Value |
---|---|
Number of patients/eyes | 40/41 |
Age (range, years) | 55.95 (22–79) |
Sex (female/male) | 18 (45)/22 (55) |
Table 2.
Variable | Value |
---|---|
Number of patients with 2 reoperations | 7 |
Number of patients with 3 reoperations | 2 |
Successful/total (eyes) | 32/41* |